Article Information
History
- January 30, 2024.
Article Versions
- Version 1 (March 12, 2023 - 10:06).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Peter Georgeson1,2,
- Robert S. Steinfelder3,
- Tabitha A. Harrison3,
- Bernard J. Pope1,2,4,
- Syed H. Zaidi5,
- Conghui Qu6,
- Yi Lin3,
- Jihoon E. Joo1,2,
- Khalid Mahmood1,2,4,
- Mark Clendenning1,2,
- Romy Walker1,2,
- Elom K Aglago7,
- Sonja I. Berndt8,
- Hermann Brenner10,11,9,
- Peter T. Campbell12,
- Yin Cao13,14,15,
- Andrew T. Chan16,17,18,19,20,21,
- Jenny Chang-Claude22,23,
- Niki Dimou24,
- Kimberly F. Doheny25,
- David A. Drew16,17,
- Jane C. Figueiredo26,27,
- Amy J. French28,
- Steven Gallinger29,5,
- Marios Giannakis19,30,31,
- Graham G. Giles32,33,34,
- Ellen L Goode35,
- Stephen B Gruber36,
- Andrea Gsur37,
- Marc J. Gunter24,
- Sophia Harlid38,
- Michael Hoffmeister9,
- Li Hsu3,39,
- Wen-Yi Huang8,
- Jeroen R Huyghe3,
- JoAnn E. Manson20,31,
- Victor Moreno40,41,42,43,
- Neil Murphy24,
- Rami Nassir44,
- Christina C. Newton45,
- Jonathan A. Nowak46,
- Mireia Obón-Santacana40,41,42,
- Shuji Ogino19,20,46,47,
- Rish K. Pai48,
- Nikos Papadimitrou24,
- John D. Potter3,49,
- Robert E. Schoen50,
- Mingyang Song51,52,
- Wei Sun3,
- Amanda E. Toland53,
- Quang M. Trinh5,
- Kostas Tsilidis7,
- Tomotaka Ugai20,46,
- Caroline Y Um54,
- Finlay A. Macrae55,56,57,
- Christophe Rosty1,2,58,59,
- Thomas J. Hudson5,
- Ingrid M. Winship57,60,
- Amanda I. Phipps3,61,
- Mark A. Jenkins2,33,
- Ulrike Peters3,61,# and
- Daniel D. Buchanan1,2,57,#,*
- 1Colorectal Oncogenomics Group, Department of Clinical Pathology, The University of Melbourne, Parkville, Victoria 3010 Australia
- 2University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre, Parkville, Victoria 3010 Australia
- 3Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA
- 4Melbourne Bioinformatics, The University of Melbourne, Carlton, Australia
- 5Ontario Institute for Cancer Research, Toronto, Ontario, Canada
- 6Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA
- 7Department of Epidemiology and Biostatistics, Imperial College London, School of Public Health, London, UK
- 8Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
- 9Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany
- 10Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany
- 11German Cancer Consortium (DKTK), German Cancer Research Center(DKFZ), Heidelberg, Germany
- 12Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA
- 13Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St Louis, Missouri, USA
- 14Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri, USA
- 15Division of Gastroenterology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA
- 16Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
- 17Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
- 18Channing Division of Network Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
- 19Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA
- 20Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA
- 21Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA
- 22Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
- 23University Medical Centre Hamburg-Eppendorf, University Cancer Centre Hamburg (UCCH), Hamburg, Germany
- 24Nutrition and Metabolism Branch, International Agency for Research on Cancer, World Health Organization, Lyon, France
- 25Center for Inherited Disease Research (CIDR), Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
- 26Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA
- 27Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA
- 28Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA
- 29Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
- 30Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
- 31Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA
- 32Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia
- 33Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia
- 34Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia
- 35Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
- 36Department of Medical Oncology & Therapeutics Research, City of Hope National Medical Center, Duarte CA, USA
- 37Center for Cancer Research, Medical University Vienna, Vienna, Austria
- 38Department of Radiation Sciences, Oncology Unit, Umeå University, Umeå, Sweden
- 39Department of Biostatistics, University of Washington, Seattle, Washington, USA
- 40Unit of Biomarkers and Suceptibility (UBS), Oncology Data Analytics Program (ODAP), Catalan Institute of Oncology (ICO), L’Hospitalet del Llobregat, Barcelona, Spain
- 41Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain
- 42ONCOBEL Program, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain
- 43Department of Clinical Sciences, Faculty of Medicine and health Sciences and Universitat de Barcelona Institute of Complex Systems (UBICS), University of Barcelona (UB), L’Hospitalet de Llobregat, 08908 Barcelona, Spain
- 44Department of Pathology, College of Medicine, Umm Al-Qura University, Saudi Arabia
- 45Department of Population Science, American Cancer Society, Atlanta, Georgia
- 46Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA
- 47Cancer Immunology Program, Dana-Farber Harvard Cancer Center, Boston, Massachusetts, USA
- 48Department of Pathology and Laboratory Medicine, Mayo Clinic Arizona, Scottsdale, Arizona, USA
- 49Research Centre for Hauora and Health, Massey University, Wellington, New Zealand
- 50Departments of Medicine and Epidemiology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA
- 51Departments of Epidemiology and Nutrition, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA
- 52Clinical and Translational Epidemiology Unit and Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
- 53Departments of Cancer Biology and Genetics and Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA
- 54Department of Population Science, American Cancer Society, Atlanta, Georgia, USA
- 55Parkville Familial Cancer Centre, and Dept of Colorectal Medicine and Genetics The Royal Melbourne Hospital
- 56Colorectal Medicine and Genetics, Royal Melbourne Hospital, Parkville, Australia
- 57Genomic Medicine and Family Cancer Clinic, Royal Melbourne Hospital, Parkville, Australia
- 58Envoi Specialist Pathologists, Brisbane, Australia
- 59University of Queensland, Brisbane, Australia
- 60Department of Medicine, The University of Melbourne, Parkville, Australia
- 61Department of Epidemiology, University of Washington, Seattle, Washington, USA
- ↵*Corresponding author:
Associate Professor Daniel D. Buchanan, Head, Colorectal Oncogenomics Group, Department of Clinical Pathology, The University of Melbourne, Victorian Comprehensive Cancer Centre, 305 Grattan Street, Parkville, Victoria, 3010 Australia, Ph: +61 385597004, Email: daniel.buchanan{at}unimelb.edu.au